Navigation Links
Healthzone Limited Engages The Trout Group for Investor Relations Services

SYDNEY, March 3, 2011 /PRNewswire/ -- Healthzone Limited (ASX: HZL; OTCQX: HLTZY) announced that it has entered into a services agreement with The Trout Group LLC ("the Trout Group"), a leading New York-based investor relations and strategic advisory firm. The Trout Group will provide investor relations services for Healthzone for an initial engagement of one year.

With more than 60 current clients, the Trout Group provides investor relations and advisory services exclusively for the life sciences industry. The Trout Group will be assisting Healthzone with its corporate goal to broaden the Company's exposure to institutional investors.

"With Trout's office in Shanghai since 2009, and our long-time support in Australia, we are ideally positioned to help Healthzone meet a broad-base of global institutional investors and analysts," said Brian Korb, Senior Vice President. "Healthzone's existing revenue base of over $100 million, EBITDA of close to $10 million, and their ongoing expansion in China with the recent Eu Yan Sang alliance gives Healthzone a unique story to tell potential investors."

Peter Roach, Healthzone Executive Chairman, said, "We are already experiencing increased share liquidity as a result of the Trout Group's early initiatives and we look forward to the relationship adding value to our efforts to grow value into our share price."

ABOUT HEALTHZONE LIMITEDHealthzone Ltd operates a portfolio of distribution, consumer product and retail business and is the largest operator in the Australian Wellness sector with significant and growing Asian and China wellness market interests. Each business provides immediate opportunities for earnings growth through business development and integration. Healthzone's businesses are comprised of three principal activities; Health and Beauty distribution; Health and Beauty Products, and Health Food Retail. For further information please visit  

ABOUT THE TROUT GROUP LLCThe Trout Group is a leading investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1996, the Trout Group has been providing healthcare and biotechnology companies with expert investor relations counsel and access to the institutional investment community. Based on our experience in the biotechnology, pharmaceuticals, medical technology and life science technology sectors, the Trout Group offers our clients the knowledge to clarify investment themes and reach the proper target audience. The Trout Group's global reach extends through a network of offices and contacts in all major financial centers, helping our clients find the right investors. The Trout Group - Relationship Capital. For additional information, please visit LimitedHealthzone LimitedPeter Roach

Michael JenkinsExecutive Chairman

Company SecretaryTel: +612 9772 7100

Tel: +612 9772 7102USAAustraliaThe Trout Group

FCRInvestor Relations

Financial & Corporate RelationsBrian Korb

Ashley RambukwellaTel: +1 646 378 2923

Tel: +61 2 9235 1666

SOURCE Healthzone Limited
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
2. EnrichMap Announces New Program To Reduce Medical Patient Noncompliance And Offers Healthcare Organizations A Limited Trial Test Opportunity
3. Solos Endoscopy, Inc. in Final Stages to Upgrade Pink Sheet Status from Limited to Current Information
4. Bunge Limited Schedules Third Quarter 2008 Earnings Release and Conference Call
5. Red Herring Awards ProGenTech Limited for the 2008 Red Herring Asia 100
6. Boston Scientific Acquires Labcoat Limited
7. Circ Pharma Limited Enters Into Development Agreement for Chrono Tramadol With Elan Corporation Plc
8. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
9. Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
10. Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process: From Lab to Plant
11. Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited
Post Your Comments:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. β€œIn further expanding our ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the ... the Dow Jones Industrial Average edged 0.27% lower to finish ... 0.17%. has initiated coverage on the following equities: Infinity ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... ). Learn more about these stocks by accessing their free ...
(Date:6/23/2016)... June 23, 2016 ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... . The Global Cell ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):